Heath E - Search Results

1

Lycopene in cancer prevention and treatment.

Seren S, Lieberman R, Bayraktar UD, Heath E, Sahin K, Andic F, Kucuk O. Seren S, et al. Among authors: heath e. Am J Ther. 2008 Jan-Feb;15(1):66-81. doi: 10.1097/MJT.0b013e31804c7120. Am J Ther. 2008. PMID: 18223356 Review.

2

Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.

Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, Cher ML, Andic F, Rossi PJ, Kucuk O. Ahmad IU, et al. Among authors: heath e. Nutr Cancer. 2010;62(7):996-1000. doi: 10.1080/01635581.2010.509839. Nutr Cancer. 2010. PMID: 20924975 Free PMC article. Clinical Trial.

3

Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions.

Rencsok EM, Bazzi LA, McKay RR, Huang FW, Friedant A, Vinson J, Peisch S, Zarif JC, Simmons S, Hawthorne K, Villanti P, Kantoff PW, Heath E, George DJ, Mucci LA. Rencsok EM, et al. Among authors: heath e. Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1374-1380. doi: 10.1158/1055-9965.EPI-19-1616. Epub 2020 Jun 5. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32503813 Free PMC article.

4

Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.

Nazha B, Zhuang T, Wu S, Brown JT, Magee D, Carthon BC, Kucuk O, Nabhan C, Barata PC, Heath EI, Ryan CJ, McKay RR, Master VA, Bilen MA. Nazha B, et al. Cancer. 2023 Dec 15;129(24):3884-3893. doi: 10.1002/cncr.34982. Epub 2023 Aug 11. Cancer. 2023. PMID: 37565840

5

A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, Tan W, Ivy SP, Pili R, Carducci MA, Erlichman C, Liu G. Heath EI, et al. Clin Cancer Res. 2008 Dec 1;14(23):7940-6. doi: 10.1158/1078-0432.CCR-08-0221. Clin Cancer Res. 2008. PMID: 19047126 Free PMC article. Clinical Trial.

6

ALK inhibitors in lung cancer.

Heath E. Heath E. Clin Adv Hematol Oncol. 2009 Oct;7(10):649-50. Clin Adv Hematol Oncol. 2009. PMID: 20040904 No abstract available.

7

Angiogenesis inhibitors in the treatment of prostate cancer.

Hwang C, Heath EI. Hwang C, et al. J Hematol Oncol. 2010 Aug 2;3:26. doi: 10.1186/1756-8722-3-26. J Hematol Oncol. 2010. PMID: 20678204 Free PMC article. Review.

8

Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone.

Zheng Q, Sha X, Liu J, Heath E, Lorusso P, Li J. Zheng Q, et al. Among authors: heath e. Mol Cancer Ther. 2010 Oct;9(10):2803-13. doi: 10.1158/1535-7163.MCT-10-0597. Epub 2010 Aug 16. Mol Cancer Ther. 2010. PMID: 20713530

9

A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumors.

Heath EI, Chiorean EG, Sweeney CJ, Hodge JP, Lager JJ, Forman K, Malburg L, Arumugham T, Dar MM, Suttle AB, Gainer SD, LoRusso P. Heath EI, et al. Clin Pharmacol Ther. 2010 Dec;88(6):818-23. doi: 10.1038/clpt.2010.199. Epub 2010 Oct 27. Clin Pharmacol Ther. 2010. PMID: 20980999 Clinical Trial.

10

Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults.

Bajaj M, Heath EI. Bajaj M, et al. Expert Opin Biol Ther. 2011 Nov;11(11):1519-24. doi: 10.1517/14712598.2011.610788. Epub 2011 Aug 31. Expert Opin Biol Ther. 2011. PMID: 21877997 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page